Found: 205
Select item for more details and to access through your institution.
Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1463341
- By:
- Publication type:
- Article
Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1068, doi. 10.4143/crt.2024.008
- By:
- Publication type:
- Article
Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non–Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1084, doi. 10.4143/crt.2024.084
- By:
- Publication type:
- Article
Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAF<sup>V600E</sup>-Mutated Thyroid Cancer.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1270, doi. 10.4143/crt.2023.1278
- By:
- Publication type:
- Article
Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 8, p. 2459, doi. 10.1007/s00432-021-03527-4
- By:
- Publication type:
- Article
Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 12, p. 3359, doi. 10.1007/s00432-020-03316-5
- By:
- Publication type:
- Article
Impact of EGFR mutation on the clinical efficacy of PD-1 inhibitors in patients with pulmonary adenocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 5, p. 1341, doi. 10.1007/s00432-019-02889-0
- By:
- Publication type:
- Article
Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 8, p. 1203, doi. 10.1007/s00432-011-0986-0
- By:
- Publication type:
- Article
The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 4, p. 687, doi. 10.1007/s00432-010-0928-2
- By:
- Publication type:
- Article
Prognostic Value of Radiomic Analysis Using Pre- and Post-Treatment 18 F-FDG-PET/CT in Patients with Laryngeal Cancer and Hypopharyngeal Cancer.
- Published in:
- Journal of Personalized Medicine, 2024, v. 14, n. 1, p. 71, doi. 10.3390/jpm14010071
- By:
- Publication type:
- Article
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 532, doi. 10.1002/cpdd.427
- By:
- Publication type:
- Article
Will the requirement by the US FDA to simultaneously co-develop companion diagnostics (CDx) delay the approval of receptor tyrosine kinase inhibitors for RTK-rearranged (ROS1-, RET-, AXL-, PDGFR-α-, NTRK1-) non-small cell lung cancer globally?
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00058
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery.
- Published in:
- Journal of Korean Neurosurgical Society, 2021, v. 64, n. 2, p. 271, doi. 10.3340/jkns.2020.0135
- By:
- Publication type:
- Article
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer.
- Published in:
- European Journal of Immunology, 2021, v. 51, n. 4, p. 956, doi. 10.1002/eji.202048966
- By:
- Publication type:
- Article
MDSC subtypes and CD39 expression on CD8<sup>+</sup> T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC.
- Published in:
- European Journal of Immunology, 2020, v. 50, n. 11, p. 1810, doi. 10.1002/eji.202048534
- By:
- Publication type:
- Article
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 5, p. 594, doi. 10.1093/jjco/hyaa019
- By:
- Publication type:
- Article
Different clinical outcomes between locally advanced hypopharyngeal and oropharyngeal cancer treated with definitive concurrent chemoradiotherapy: implication for subgroup selection for induction chemotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 1, p. 40, doi. 10.1093/jjco/hyv163
- By:
- Publication type:
- Article
Outcomes of Curative-Intent Surgery and Adjuvant Treatment for Pulmonary Large Cell Neuroendocrine Carcinoma.
- Published in:
- World Journal of Surgery, 2017, v. 41, n. 7, p. 1820, doi. 10.1007/s00268-017-3908-8
- By:
- Publication type:
- Article
Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Absence of Clinical Prognostic Value of Vascular Endothelial Growth Factor and Microvessel Density in Multiple Myeloma.
- Published in:
- International Journal of Hematology, 2002, v. 76, n. 5, p. 460, doi. 10.1007/BF02982812
- By:
- Publication type:
- Article
Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With MET Exon 14 Skipping.
- Published in:
- In Vivo, 2020, v. 34, n. 3, p. 1399, doi. 10.21873/invivo.11920
- By:
- Publication type:
- Article
Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer.
- Published in:
- APMIS, 2009, v. 117, n. 12, p. 861, doi. 10.1111/j.1600-0463.2009.02545.x
- By:
- Publication type:
- Article
L1 cell adhesion molecule as a predictor for recurrence in pulmonary carcinoids and large-cell neuroendocrine tumors.
- Published in:
- APMIS, 2009, v. 117, n. 2, p. 140, doi. 10.1111/j.1600-0463.2009.02433.x
- By:
- Publication type:
- Article
Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray.
- Published in:
- APMIS, 2006, v. 114, n. 9, p. 619, doi. 10.1111/j.1600-0463.2006.apm_401.x
- By:
- Publication type:
- Article
The prognostic value of radiomic features from pre- and post-treatment <sup>18</sup>F-FDG PET imaging in patients with nasopharyngeal carcinoma.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-35582-x
- By:
- Publication type:
- Article
Prognostic value of pretherapeutic FDG PET/CT in non-small cell lung cancer with pulmonary lymphangitic carcinomatosis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-022-24875-2
- By:
- Publication type:
- Article
CpG oligodeoxynucleotides induce IL-8 expression in CD34+ cells via mitogen-activated protein kinase-dependent and NF-κB-independent pathways.
- Published in:
- International Immunology, 2005, v. 17, n. 12, p. 1525, doi. 10.1093/intimm/dxh345
- By:
- Publication type:
- Article
Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 6, p. 2083, doi. 10.1245/s10434-014-3540-x
- By:
- Publication type:
- Article
Volume-Based Parameter of F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2010, v. 17, n. 10, p. 2787, doi. 10.1245/s10434-010-1107-z
- By:
- Publication type:
- Article
Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Characteristics and outcomes of ALK+ non-small cell lung cancer patients in Korea.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 5, p. e239, doi. 10.1111/ajco.12645
- By:
- Publication type:
- Article
An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small cell lung cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 4, p. 380, doi. 10.1111/ajco.12513
- By:
- Publication type:
- Article
An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, p. 13, doi. 10.1111/j.1743-7563.2011.01398.x
- By:
- Publication type:
- Article
Comparative effectiveness of bevacizumab plus cisplatin-based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non-squamous non-small cell lung cancer patients applying real-life outcomes.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, p. 34, doi. 10.1111/j.1743-7563.2011.01400.x
- By:
- Publication type:
- Article
Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, p. 22, doi. 10.1111/j.1743-7563.2011.01399.x
- By:
- Publication type:
- Article
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 265, doi. 10.1007/s10637-021-01121-6
- By:
- Publication type:
- Article
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 360, doi. 10.1007/s10637-019-00795-3
- By:
- Publication type:
- Article
Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 782, doi. 10.1007/s10637-017-0463-y
- By:
- Publication type:
- Article
AZD9291 overcomes T790 M-mediated resistance through degradation of EGFR in non-small cell lung cancer cells.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 4, p. 407, doi. 10.1007/s10637-016-0350-y
- By:
- Publication type:
- Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 12, doi. 10.1007/s10637-014-0163-9
- By:
- Publication type:
- Article
Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (MYSTIC).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 301, doi. 10.1016/j.cllc.2021.02.010
- By:
- Publication type:
- Article